Occidental Petroleum
OXY
The Kraft Heinz
KHC
Chevron
CVX
The Kroger
KR
VeriSign
VRSN
US Stock MarketDetailed Quotes
RLMD Relmada Therapeutics
- 0.316
- -0.017-5.02%
Trading Feb 18 12:25 ET
9.54MMarket Cap-0.11P/E (TTM)
0.346High0.315Low437.39KVolume0.345Open0.333Pre Close141.08KTurnover1.59%Turnover RatioLossP/E (Static)30.17MShares7.22352wk High0.20P/B8.71MFloat Cap0.28052wk Low--Dividend TTM27.54MShs Float54.000Historical High--Div YieldTTM9.16%Amplitude0.280Historical Low0.322Avg Price1Lot Size
Relmada Therapeutics Key Stats
EPS
According to the latest financial report of Relmada Therapeutics, the latest earnings per share (TTM) for the company is -0.72. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Relmada Therapeutics's free cash flow? The latest report shows it as -16.66M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Relmada Therapeutics shows that the company's current ratio is 6.89, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Relmada Therapeutics, the quick ratio is 6.69, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Relmada Therapeutics? The latest ROE figure is -39.82%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Relmada Therapeutics, the total asset return on investment (ROA) is -34.28%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Relmada Therapeutics's latest financial report to see how their gross margin is doing - currently at -0.44%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Relmada Therapeutics, the net profit margin is -458.06%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.